Searched for
MID STAGE TRIAL
GSK's Jemperli meets main goal in mid-stage rectal cancer trialGSK's cancer drug Jemperli met a key goal in a mid-stage trial. This drug targets a specific rectal cancer subtype affecting a small percen...- Australia's teen social media ban fails to clear first hurdle in age checks, says studyAustralian online platforms are failing initial age checks for a teen social media ban. Studies show most under-16s can still access platfo...
- Australia's teen social media ban fails to clear first hurdle in age checks, says studySince December, Australia's new social media law has mandated that platforms including Instagram, Snapchat and YouTube bar people under 16 ...
- No slowdown yet, but inflation and El Niño are risks: ITC's Sanjiv PuriITC Chairman Sanjiv Puri revealed plans for a Rs 20,000 crore investment over the medium term, including hotel expansion. He highlighted st...
- Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...
- What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
- Amazon primes a Blinkit showdown; New insurance models prop upHappy Tuesday! Amazon's late but strong push into quick commerce is unsettling market leader Blinkit. This and more in today's ETtech Morni...
- Mark Zuckerberg backed-Cellular Intelligence acquires Novo Nordisk's Parkinson's cell therapyLast October, Novo Nordisk had shut down its cell therapy unit as part of a broader restructuring, discontinuing development of the therap...
- US market today: Biotech firm Odyssey hits nearly $900 million valuation as shares rise in Nasdaq debutOdyssey Therapeutics debuted on Nasdaq with an 11.1% surge, reaching a $899.9 million valuation. The autoimmune disease specialist successf...
- Netanyahu cancer: Israel Prime Minister's health report reveals prostate cancer treatment, details aftermath of surgery at Jerusalem hospitalIsrael PM Benjamin Netanyahu cancer treatment: 76-year-old Prime Minister underwent surgery at medical center in Jerusalem.
- Weight-loss treatment: How has obesity medicine market become battleground for pharma giants like Pfizer, AstraZeneca, Eli Lilly?Obesity, weight-loss medicines: Novo has been scrambling to keep pace in the obesity drug race it started, losing ground to rival Eli Lilly...
- Explained: Where does the world stand in the race for a coronavirus vaccine?The following is what we know about the race to deliver vaccines to help end the coronavirus pandemic, which has killed more than 1.8 milli...
- Explained: Where are we in the COVID-19 vaccine race?The European Union gave approval on Dec. 21 for the COVID-19 vaccine developed by Pfizer Inc and BioNTech SE, the latest regulatory go-ahea...
- Where are we in the COVID-19 vaccine race?AstraZeneca said on Nov. 23 it will immediately prepare the data to submit to regulatory authorities around the world that offer conditiona...
- AstraZeneca's cancer drug fails to meet main goal in COVID-19 trialsThe drugmaker called the results from the study disappointing but said it remained committed to its clinical trials for its COVID-19 vaccin...
- Bharat Biotech in talks to take COVID-19 vaccine candidate globalThe potential vaccine was found to be safe without any major adverse events in the first two stages of the trials involving about 1,000 peo...
- AstraZeneca resumes vaccine trial in Japan, in talks with U.S.Several global trials of the vaccine, AZD1222, were put on hold last month after an unexplained illness in a study participant. While most ...
- Novavax aims for 2 bn COVID-19 vaccine doses with expanded India dealU.S. drug developer Novavax Inc said on Tuesday it was doubling its potential COVID-19 vaccine manufacturing capacity to two billion doses ...
- Testing of China’s candidate vaccine begins in RussiaThe Ad5-nCoV vaccine already has approval for use by China’s military after early and mid-stage trials, and further late-stage trials are b...
- Sharekhan recommends ‘buy’ on Cadila HealthcareSharekhan has recommended ‘buy’ on Cadila Healthcare with a target price of Rs.372. At the current market price of Rs272, the stock is avai...
Load More
